KV Pharmaceutical axes 44% of workforce
This article was originally published in Scrip
Executive Summary
KV Pharmaceutical Companyis to cut 700 jobs as part of a cost-cutting effort to reduce its overheads and resume operations. The company has been running a skeleton operation following a series of suspensions, product recalls and non-approvals.